Despite management guidelines advocating statin/ezetimibe use in very high cardiovascular risk (CV) conditions, adherence to this therapy is still suboptimal and LDL-C target attainment unsatisfactory. We aimed to investigate the level of adherence to statin/ezetimibe and LDL-C target achievement rates in an unselected very high CV risk population in primary care setting in Italy.
Guglielmi, V., Bellia, A., Pecchioli, S., DELLA MORTE, D., Parretti, D., Cricelli, I., et al. (2017). Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. ATHEROSCLEROSIS, 263, 36-41 [10.1016/j.atherosclerosis.2017.05.018].
Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care
GUGLIELMI, VALERIA;BELLIA, ALFONSO;DELLA MORTE, DAVID;SBRACCIA, PAOLO;LAURO, DAVIDE;
2017-01-01
Abstract
Despite management guidelines advocating statin/ezetimibe use in very high cardiovascular risk (CV) conditions, adherence to this therapy is still suboptimal and LDL-C target attainment unsatisfactory. We aimed to investigate the level of adherence to statin/ezetimibe and LDL-C target achievement rates in an unselected very high CV risk population in primary care setting in Italy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Adherence Statins Atherosclerosis 2017.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
487.33 kB
Formato
Adobe PDF
|
487.33 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
